ClinicalTrialExchange
  • Home
  • For Patients
  • For Professionals
  • About
  • Contact

Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Penile Induration

  • Delayed Dose Collagenase Clostridium Histolyticum (CCH) Protocol for Men With Peyronie's Disease
  • Concurrent Low Intensity Shockwave Therapy on Collagenase Clostridium Histolyticum for Peyronie's Disease
  • Intralesional Hyaluronic Acid and Verapamil Injection in Peyronie's Disease
  • Safety and Efficacy of Collagenase Clostridium Histolyticum After Prior Intralesional PRP for Peyronie's Disease
  • Focused Shock Wave Therapy Outcomes in Peyronie's Disease and Erectile Dysfunction
  • Efficacy of a Novel CCH Protocol for PD Among Prior Non-responders
  • Investigation of Surgery, Collagenase, and Restorex for the Improvement of Peyronie's
  • Stem Cell Treatment of Peyronie´s Disease.
  • PRP for Treatment of Peyronie's Disease
  • Xiaflex® Plus Testosterone Treatment Pilot Study Protocol
  • Treatment Response to Xiaflex for Men With Peyronie's Disease
  • Additional Xiaflex® Treatment in Patients With Peyronie's Disease Recurrence, Worsening, or Incomplete Response
  • Management of Peyronie's Disease With Adipose Tissue Stem Cell
  • Long-term Safety, Curvature Deformity Characterization, and Immunogenicity Over Time in Subjects Previously Treated With AA4500 for Peyronies Disease
  • Peyronie's Disease Treatment Protocol
  • Testosterone Pellets Plus Vitamin D and E Versus Vitamin D and E Alone for the Treatment of Peyronie's Disease
  • H-22411: BOTOX® for Peyronie's Disease
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies

Clinical Trials data from clinicaltrials.gov

Powered by DrugPatentWatch.

  • About
  • Contact
  • Follow ClinicalTrialsExchange:

      ClinicalTrialsExchange Linkedin Group